Sector
PharmaceuticalsCMP
as on 03 Jul, 2024 12:00:00 AM
Open
₹51.66Prev. Close
₹53.09Turnover(Lac.)
₹1.05Day's High
₹55.74Day's Low
₹5152 Week's High
₹61.5852 Week's Low
₹22.11Book Value
₹8.87Face Value
₹10Mkt Cap (₹ Cr.)
36.67P/E
0EPS
0Divi. Yield
013 Jun 2023
12:00 AM
AGM
Announcement Date: 13 Jun, 2023
17 May 2024
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 6.83 | 6.83 | 6.83 | 6.83 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 3.98 | 5.23 | 6.83 | 6.58 |
Net Worth | 10.81 | 12.06 | 13.66 | 13.41 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 19.89 | 24.45 | 20.17 | 14.35 |
yoy growth (%) | -18.64 | 21.18 | 40.52 | -33.54 |
Raw materials | -14.57 | -17.79 | -10.85 | -6.73 |
As % of sales | 73.27 | 72.76 | 53.78 | 46.88 |
Employee costs | -1.49 | -1.58 | -1.81 | -1.54 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 0.47 | 0.96 | 0.67 | 0.26 |
Depreciation | -0.34 | -0.39 | -0.46 | -0.44 |
Tax paid | -0.16 | -0.42 | -0.1 | -0.1 |
Working capital | 0.19 | 2.02 | 0.06 | 0.41 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -18.64 | 21.18 | 40.52 | -33.54 |
Op profit growth | -107.56 | 24.37 | 397.72 | -39.1 |
EBIT growth | -50.83 | 38.23 | 162.62 | 7.53 |
Net profit growth | -42.2 | -5.76 | 252.55 | 289.14 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,529.55 | 120.29 | 3,65,682.64 | 867.6 | 0.89 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,565 | 76.97 | 1,21,312.5 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,481.15 | 32.36 | 1,20,195.02 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,097.05 | 31.35 | 1,08,114.81 | 1,405.2 | 0.28 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,498.85 | 24.48 | 1,06,298.05 | 1,034.8 | 0.63 | 5,081.8 | 1,453.02 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Non Executive Director
Vinay Ramakant Sapte
Non Executive Director
Maneesh R Sapte
Whole-time Director
Y N Bhaskara Rao
Non Executive Director
Rashmi V Sapte
Independent Director
PRAVIN M. HEGDE
Independent Director
Ajit G Jamkhandikar
Company Sec. & Compli. Officer
Urvashi Bhatia
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Phaarmasia Ltd
Summary
Incorporated in 1981, Phaarmasia Limited (unit-I) is the part of the Maneesh Pharmaceutical Limited, with its headquarters and marketing office in Mumbai. M/s Phaarmasia Limited Unit-II was established in 1993-94. The Company is engaged in manufacturing and marketing of Oral contraceptive tablets with various therapeutic dosage combinations along with iron tablets for Ministry of Health & Family Welfare and for Exports. The plant is situated in a hygienic environment; free from dust, smoke, chemical & biological emission. Phaarmasia Ltd. Is an independent State-of-the-art-manufacturing unit having manufacturing facility of international standards with manufacturing capacity of more than 30 million units per annum. During the year 2000, the company became a Sick Industrial Company under SICA and therefore the same was referred to the BIFR.During past a few decades, Phaarmasia mastered and manufactured wide range of Pharmaceutical Formulations at a WHO-GMPcertified and ISO 9001-certified manufacturing facility.
Read More
What is the Phaarmasia Ltd share price today?
The Phaarmasia Ltd shares price on nse is Rs.₹53.69 today.
What is the Market Cap of Phaarmasia Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Phaarmasia Ltd is ₹36.67 Cr. as of 03 Jul ‘24
What is the PE and PB ratio of Phaarmasia Ltd?
The PE and PB ratios of Phaarmasia Ltd is 0 and 6.05 as of 03 Jul ‘24
What is the 52 Week High and Low of Phaarmasia Ltd?
The 52-week high/low is the highest and lowest price at which a Phaarmasia Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Phaarmasia Ltd is ₹22.11 and ₹61.58 as of 03 Jul ‘24
What is the CAGR of Phaarmasia Ltd?
Phaarmasia Ltd's CAGR for 5 Years at 21.62%, 3 Years at 11.31%, 1 Year at 120.57%, 6 Month at 34.07%, 3 Month at 69.67% and 1 Month at 47.27%.
What is the shareholding pattern of Phaarmasia Ltd?
The shareholding pattern of Phaarmasia Ltd is as follows:
Promoters - 73.51 %
Institutions - 0.06 %
Public - 26.43 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
